Canine mammary carcinoma cell line are resistant to chemosensitizers: Verapamil and cyclosporin A

Polish Journal of Veterinary Sciences

Volumn 17, Issue 1, 2014, Pages 9-17

  Krol M ^a   Pawlowski K M ^a   Majchrzak, K ^a   Mucha, J ^a   Motyl, T ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

canine mammary cancer; glycoprotein P; multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; VINBLASTINE;

ADENOCARCINOMA; ANIMAL; ARTICLE; DOG; DOG DISEASE; DRUG ANTAGONISM; DRUG POTENTIATION; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYCLOSPORINE; DOG DISEASES; DOGS; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; P-GLYCOPROTEINS; VERAPAMIL; VINBLASTINE;

EID: 84900513827     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: 10.2478/pjvs-2014-0002     Document Type: Article

References (25)

1. Arboix M, Gonzales Paz O, Colombo T, D'Incalci M (1997) Multidrug Resistance-Reversing Agents Increase Vin-blastine Distribution in Normal Tissues Expressing the P-Glycoprotein but Do Not Enhance Drug Penetration in Brain and Testis. JPET 281: 1226-1230.
2. Brinkhof B, Spee B, Rothuizen J, Penning LC (2006) Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem 356: 36-43.
3. Colombo T, Zucchetti M, D'Incalci M (1994) Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. J Pharmacol Exp Ther 269: 22-27.
4. Darzynkiewicz Z, Robinson JP, Crissman HA (1994) Methods in cell biology, Vol 41, Flow Cytometry, 2nd ed., Part A.
5. Etschmann B, Wilcken, B, Stoevesand K, von der Schulen-burg A, Sterner-Kock A (2006) Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm. Vet Pathol 43: 934-942.
6. Jordan MA, Thrower D, Wilson L (1992) Effects of vinblas-tine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci 102: 401-416.
7. Król M, Pawłowski KM, Majchrzak K, Szyszko K, Motyl T (2010) Why chemotherapy can fail? Pol J Vet Sci 1: 399-406.
8. Król M, Pawłowski KM, Skierski J, Rao NA, Hellmen E, Mol JA, Motyl T (2009) Transcryptomic profile of two canine mammary cancer cell lines with different prolif-erative and anti-apoptotic potential. J Physiol Pharmacol 60: 95-106.
9. Król M, Pawłowski KM, Skierski J, Turowski P, Majewska A, Polanska J, Ugorski M, Morty RE, Motyl T (2010) Tran-scriptomic "portraits" of canine mammary cancer cell lines with various phenotypes. J Appl Genet 51: 169-183.
10. Król M, Polanska J, Pawłowski KM, Turowski P, Skierski J, Majewska A, Ugorski M, Morty RE, Motyl T (2010) Transcriptomic signature of cell lines isolated from mammary adenocarcinoma metastases to lungs. J Appl Genet 51: 37-50.
11. Lee JJ, Hughes CS, Fine RL, Page RL (1996) P-Glycop-rotein Expression in Canine Lymphoma: A Relevant, Intermediate Model of Multidrug Resistance. Cancer 77: 1892-1898.
12. Lieberman DM, Reithmeier RA, Ling V, Charuk JH, Goldberg H, Skorecki KL (1989) Identification of P-glycop-rotein in renal brush border membranes. Biochem Bi-ophys Res Commun 162: 244-252.
13. Limtrakul P, Anuchapreeda S, Buddhasukh D (2004) Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4: 13.
14. Linn SC, Giaccone G, van Diest PJ, Blokhuis WM, van der Valk P, van Kalken CK, Kuiper CM, Pinedo HM, Baak JP (1995) Prognostic relevance of P-glycoprotein expression in brest cancer. Ann Oncol 6: 679-685.
15. Majchrzak K, Pawlowski KM, Orzechowska EJ, Dolka I, Mucha J, Motyl T, Król M (2012) A role of ghrelin in canine mammary carcinoma cells proliferation, apoptosis and migration. BMC Vet Res 8: 170.
16. Merlin JL, Guerci A, Marchal S, Missoum N, Ramacci C, Humbert JC, Tsuruo T, Guerci O (1994) Comparative Evaluation of S9788, Verapamil, and Cyclosporine A in K562 Human Leukemia Cell Lines and in P-Glycop-rotein-Expressing Samples From Patients With Hema-tologic Malignancies. Blood 84: 262-269.
17. Morrison LC, McClelland R, Aiken C, Bridges M, Liang L, Wang X, Di Curzio D, Del Bigio MR, Taylor MD, Wer-bowetski-Ogilvie TE (2013) Deconstruction of Medul-loblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes. Neoplasia 15: 384-398.
18. Nadir M, O'Loughlin KL, Fricke SM, Williamson NA, Greco WR, Minderman H, Baer MR (2005) Cyclosporin A is a broad-spectrum multidrug resistance modulator. Clin Cancer Res 11: 2320-2326.
19. Palmeira A, Sousa E, Vasconcelos MH, Pinto MM (2012) Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19: 1946-2025.
20. Pawłowski KM, Król M, Majewska A, Badowska-Kozakiewicz A, Mol JA, Malicka E, Motyl T (2009) Comparison of cellular and tissue transcriptional profiles in canine mammary tumor. J Physiol Pharmacol 60: 85-94.
21. Pawłowski KM, Mucha J, Majchrzak K, Motyl T, Król M (2013) Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells. BMC Vet Res 9: 119.
22. Perrotton T, Trompie D, Chang XB, Di Pietro A, Baubichon-Cortay H (2007) (R)-and (S)-Verapamil Differentially Modulate the Multidrug-resistant Protein MRP1. J Biol Chem 282: 31542-31548.
23. Petterino C, Rossetti E, Bertoncello D, Martini M, Zappulli V, Bargelloni L, Castagnaro M (2006) Immunohis-tochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours. J Vet Med A Physiol Pathol Clin Med 53: 174-178.
24. T method. Nat Protoc 3: 1101-1108.
25. Turker MS, Duffin KZ, Smith AC, Martin GM, Martin AW, DiMartino DL, Kersey DS (1991) Multidrug resistance phenotype associated with selection of aminopterin resistant dog kidney cell line. Pharmacogenetics 11: 149-160.